This article refers to:
Article title: Impact of lixisenatide dose range on clinical outcomes with fixed-ratio combination iGlarLixi in patients with type 2 diabetes
Authors: Frias, J. P., Lorenz, M., Roberts, M., Dex, T., Schmider, W., Hurst, W., & Skolnik, N.
Journal: Current Medical Research and Opinion
DOI: https://dx.doi.org/10.1080/03007995.2018.1541316
When this paper was first published online, Figures 2b and 2c were missing from the typeset article PDF.
Figures 2b and 2c have now been added to the typeset paper and the article has been republished online.
